SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

08 May 2025 Evaluate
A fair growth of 20.88% in the revenue at Rs. 6438.00 millions was reported in the March 2025 quarter as compared to Rs. 5326.00 millions during year-ago period.The Profit  for the quarter ended March 2025 of  Rs. 212.00  millions  grew by 51.43% from Rs. 140.00 millions.Operating Profit saw a handsome growth to 1247.00 millions from 911.00 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 6438.00 5326.00 20.88 22426.00 21273.00 5.42 22426.00 21273.00 5.42
Other Income 627.00 389.00 61.18 2423.00 1930.00 25.54 2423.00 1930.00 25.54
PBIDT 1247.00 911.00 36.88 4181.00 4557.00 -8.25 4181.00 4557.00 -8.25
Interest 567.00 395.00 43.54 2369.00 1988.00 19.16 2369.00 1988.00 19.16
PBDT 680.00 516.00 31.78 7887.00 2714.00 190.60 7887.00 2714.00 190.60
Depreciation 330.00 298.00 10.74 1278.00 1211.00 5.53 1278.00 1211.00 5.53
PBT 350.00 218.00 60.55 6609.00 1503.00 339.72 6609.00 1503.00 339.72
TAX 138.00 78.00 76.92 516.00 310.00 66.45 516.00 310.00 66.45
Deferred Tax -127.00 171.00 -174.27 11.00 159.00 -93.08 11.00 159.00 -93.08
PAT 212.00 140.00 51.43 6093.00 1193.00 410.73 6093.00 1193.00 410.73
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 19.37 17.10 13.24 18.64 21.42 -12.97 18.64 21.42 -12.97

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×